Open House Originale Rabattverträge 2025-08 - Roxadustat
Original notice title
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-08 - Roxadustat
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Contract ends automatically at the end of the month when patent/market exclusivity expires, which could happen earlier...
No estimated value or guaranteed volume; revenue dependent on actual uptake.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Mar 2027
- Conclusion of rebate contracts under § 130c SGB V for the active ingredient Roxadustat.
- Uniform contractual conditions, no individual negotiations.
Show full summary
Open House procedure for discount agreements on the active ingredient Roxadustat under German law (SGB V). Techniker Krankenkasse (lead buyer) and Handelskrankenkasse (non-lead) intend to conclude non-exclusive rebate contracts with all eligible pharmaceutical entrepreneurs. One lot, no estimated value provided. The procedure allows joining at any time during the contract term (max. 24 months). Submission is not via eProcurement but by email or post. The contract ends automatically upon patent expiry. No analyzed procurement documents beyond the notice.
Risks
Contract ends automatically at the end of the month when patent/market exclusivity expires, which could happen earlier...
No estimated value or guaranteed volume; revenue dependent on actual uptake.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as per § 4(18) AMG with a valid marketing authorization for the drug.
- Must have registered office in Germany, EU, or EEA.
Eligibility
- Must declare no exclusion grounds under §§ 123, 124 GWB (criminal convictions, etc.).
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Originale Rabattverträge 2025-08 - Roxadustat
Discount agreement for Roxadustat with uniform conditions; no exclusivity; maximum term from 01.04.2025 to 31.03.2027; early termination upon patent expiry.
Location
Duration
Category
Deadline
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zum Wirkstoff Roxadustat zu schließen.
Value note
Show original TED data
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zum Wirkstoff Roxadustat zu schließen.
Procurement Details
- Publication date
- 05 Mar 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 147964-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Contract ends automatically at the end of the month when patent/market exclusivity expires, which could happen earlier...
No estimated value or guaranteed volume; revenue dependent on actual uptake.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications